Gray Television, Inc. (NYSE:GTN) is known to be undergoing restructuring in its business. The company is seeking to increase efficiency and achieve more growth. That is happening at a time when broadcast television operators are facing intense competition from Internet for advertisement revenue. That being the situation; the company is trying to take more costs and expenses control measures. Also, the company is inking more business deals aimed at boosting revenue.Gray Television, Inc. (NYSE:GTN) shares after opening at $10.62 moved to $11.88 on last trade day and at the end of the day closed at $11.36. Company price to sales ratio in past twelve months was calculated as 1.74 and price to cash ratio as 15.15. Gray Television, Inc. (NYSE:GTN) showed a positive weekly performance of 5.19%.
Prothena Corporation plc (Nasdaq:PRTA) announced the successful start of a Phase 1 clinical trial of its therapeutic monoclonal antibody candidate, PRX002, for the treatment of Parkinson’s disease. Prothena has earned a $15 million milestone payment from Roche related to the initiation of this study.Prothena Corporation PLC (NASDAQ:PRTA) shares advanced 13.34% in last trading session and ended the day on $33.90. PRTA return on equity ratio is recorded as -37.50% and its return on assets is -35.20%. Prothena Corporation PLC (NASDAQ:PRTA) yearly performance is 355.65%.
Corporate Resource Services Inc (NASDAQ:CRRS), a diversified technology, staffing, recruiting and consulting services firm, announced that it has been awarded a three year Managed Service Provider/Vendor Management Services agreement with SBM.Corporate Resource Services has been awarded this contract to service SBM in every location they provide their services globally,” said Frank Vaccaro, President of Sales for CRS. “SBM is a global provider of facility services and CRS will be the Managed Service Provider that administers this program throughout all of SBM. The MSP/VMS service offerings create immediate shareholder value and we have other major prospective MSP/VMS agreements pending client approval.Corporate Resource Services Inc (NASDAQ:CRRS) shares moved up 12.89% in last trading session and was closed at $2.89, while trading in range of $2.62-$2.91. Corporate Resource Services Inc (NASDAQ:CRRS) year to date performance is 9.89%.
Cytokinetics, Inc. (NASDAQ:CYTK) announced that the COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) expansion phase, has opened for enrollment. Cytokinetics stated that COSMIC-HF is a Phase II double-blind, randomized, placebo-controlled, multicenter clinical trial designed to assess the pharmacokinetics and tolerability of omecamtiv mecarbil dosing orally in patients with heart failure and left ventricular systolic dysfunction. Cytokinetics, Inc. (NASDAQ:CYTK) weekly performance is 2.70%. On last trading day company shares ended up $9.90. Cytokinetics, Inc. (NASDAQ:CYTK) distance from 50-day simple moving average is 6.82%. Analysts mean target price for the company is $22.71.